- Home
- RCEL vs EUDA Comparison
RCEL vs EUDA Comparison
Compare RCEL & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- EUDA
- Stock Information
- Founded
- RCEL N/A
- EUDA 2021
- Country
- RCEL United States
- EUDA Singapore
- Employees
- RCEL N/A
- EUDA N/A
- Industry
- RCEL Medical/Dental Instruments
- EUDA Blank Checks
- Sector
- RCEL Health Care
- EUDA Finance
- Exchange
- RCEL Nasdaq
- EUDA Nasdaq
- Market Cap
- RCEL 170.8M
- EUDA 146.0M
- IPO Year
- RCEL N/A
- EUDA N/A
- Fundamental
- Price
- RCEL $5.62
- EUDA $3.65
- Analyst Decision
- RCEL Strong Buy
- EUDA
- Analyst Count
- RCEL 4
- EUDA 0
- Target Price
- RCEL $17.25
- EUDA N/A
- AVG Volume (30 Days)
- RCEL 347.9K
- EUDA 76.6K
- Earning Date
- RCEL 05-08-2025
- EUDA 01-01-0001
- Dividend Yield
- RCEL N/A
- EUDA N/A
- EPS Growth
- RCEL N/A
- EUDA N/A
- EPS
- RCEL N/A
- EUDA N/A
- Revenue
- RCEL $71,661,000.00
- EUDA $4,011,005.00
- Revenue This Year
- RCEL $59.50
- EUDA $212.19
- Revenue Next Year
- RCEL $28.89
- EUDA $254.35
- P/E Ratio
- RCEL N/A
- EUDA N/A
- Revenue Growth
- RCEL 41.35
- EUDA 8.22
- 52 Week Low
- RCEL $5.46
- EUDA $2.21
- 52 Week High
- RCEL $14.16
- EUDA $6.30
- Technical
- Relative Strength Index (RSI)
- RCEL 25.54
- EUDA 45.83
- Support Level
- RCEL $6.06
- EUDA $3.62
- Resistance Level
- RCEL $6.38
- EUDA $3.80
- Average True Range (ATR)
- RCEL 0.47
- EUDA 0.27
- MACD
- RCEL -0.11
- EUDA -0.04
- Stochastic Oscillator
- RCEL 8.12
- EUDA 32.58
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.